ATR-IN-9

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

ATR-IN-9 

ATR-IN-9 是一种有效的共济失调毛细血管扩张症和 RAD-3 相关蛋白激酶 (ATR) 的抑制剂，IC50 值为 10 nM。详细信息请参考专利文献 WO2020087170A1 中的化合物 59。

ATR-IN-9

ATR-IN-9 Chemical Structure

CAS No. : 2417513-43-8

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

ATR-IN-9 is a potent inhibitor of Ataxia-telangiectasia and RAD-3-related protein kinase (ATR) extracted from patent WO2020087170A1, compound 59, has an IC50 of 10 nM[1].

IC50 & Target

IC50: 10 nM (ATR)[1]
分子量

421.50

Formula

C22H27N7O2
CAS 号

2417513-43-8
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Crane SN, et, al. Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors. WO2020087170A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务